tuberous sclerosis

Oskar, I want to switch over to you.

You enter your aspect, your business through rare genetic subtypes, Fragile X, Phelan, McDermid, Tuberous Sclerosis.

I have no medical background, so I hope I sort of pronounced it more or less correctly.

So with orphan drugs, usually the status helps, right? So isn't the hard part precisely the leap from a narrow genetic group to the much larger, idiopathic autism population that makes the market? And where does that break if it breaks? Because maybe you can tell us a bit more about how you approach the market through that very specific focus that you chose.

The fact is, could you explain exactly what is TSC?

Yeah, so TSC is short for tuberous sclerosis complex.

OK, it's a rare genetic condition that affects about a million people worldwide.

Now a person obviously is born with TSC, so they've either got it from the mum or the dad, so it's passed down, or it could just start with in them specifically.